share_log

HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $34 Price Target

HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $34 Price Target

HC Wainwright & Co.重申買入庫裏南腫瘤學,維持34美元的目標股價
Moomoo 24/7 ·  03/14 12:44

HC Wainwright & Co. analyst Edward White reiterates Cullinan Oncology (NASDAQ:CGEM) with a Buy and maintains $34 price target.

HC Wainwright & Co. 分析師愛德華·懷特重申庫裏南腫瘤學(納斯達克股票代碼:CGEM)的買入並維持34美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論